Dachaigh › Leukemia biphenotypic geur › Texas › Houston
Sgrùdaidhean clionaigeach Leukemia biphenotypic geur ann an Houston, TX
Tha aon sgrùdadh airson Leukemia biphenotypic geur a’ lorg phàirtichean aig làrach ann no faisg air Houston. Fosglaidh e gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
A’ fastadhÌre 1
- University of Texas MD Anderson Cancer Center, Houston
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
A’ fastadhÌre 2
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
A’ fastadhÌre 2
- M D Anderson Cancer Center, Houston
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A’ fastadhÌre 3
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- UT MD Anderson Cancer Center, Houston
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
A’ fastadhÌre 1/2
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- UT MD Anderson Cancer Center, Houston
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
A’ fastadhÌre 1/2
- University of Texas MD Anderson Cancer Center, Houston
Personalized NK Cell Therapy in CBT
A’ fastadhÌre 2
- M D Anderson Cancer Center, Houston
A Study of Revumenib and Mezigdomide in People With Leukemia
A’ fastadhÌre 1/2
- MD Anderson Cancer Center (Data Collection Only), Houston
Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A’ fastadhÌre 1/2
- M D Anderson Cancer Center, Houston
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
A’ fastadhÌre 2
- M D Anderson Cancer Center, Houston
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
A’ fastadhÌre 1
- Texas Children's Hospital/Baylor College of Medicine, Houston
Sgrùdaidhean Leukemia biphenotypic geur ann am bailtean eile
- Seattle, WA15 sgrùdaidhean
- New York City, NY10 sgrùdaidhean
- Atlanta, GA9 sgrùdaidhean
- Durham, NC8 sgrùdaidhean
- Memphis, TN7 sgrùdaidhean
- Chicago, IL7 sgrùdaidhean
- Charlotte, NC6 sgrùdaidhean
- Baldwin Park, CA6 sgrùdaidhean
- Aurora, CO6 sgrùdaidhean
- Dallas, TX6 sgrùdaidhean
- Philadelphia, PA6 sgrùdaidhean
- Portland, OR6 sgrùdaidhean
Sgrùdaidhean eile ann an Houston
- Aillse Sgamhain Neo-chealla-beag145 sgrùdaidhean
- Aillse a' bhroilleach126 sgrùdaidhean
- Aillse (gach seòrsa)121 sgrùdaidhean
- Ailse metastatach104 sgrùdaidhean
- Aillse colorectal102 sgrùdaidhean
- Cancer Ovarian89 sgrùdaidhean
- Leukemia myeloid geur85 sgrùdaidhean
- Ailseachadh nan Sgamhan78 sgrùdaidhean
- Aillse Prostata76 sgrùdaidhean
- Ailse Endometrial68 sgrùdaidhean
- Cancer Pancreatic61 sgrùdaidhean
- Melanoma59 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.